REQUEST A DEMO
Total
USD $0.00
Search more companies

Hyphens Pharma International Limited (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hyphens Pharma International Limited Profile Updated: May 03, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Hyphens Pharma International Limited operates as a specialty pharmaceutical and consumer healthcare company. The company offers products such as develops, markets, and distributes a range of specialty pharmaceutical, dermatological, and nutritional supplement products. Hyphens Pharma International Limited was incorporated in 2017 and is based in Singapore.

Legal Address
138 Joo Seng Road,#03-00
Singapore; Singapore; Postal Code: 368361

Contact Details: Purchase the Hyphens Pharma International Limited report to view the information.

Website: http://www.hyphens.com.sg

Basic Information
Outstanding Shares:
Purchase the Hyphens Pharma International Limited report to view the information.
Financial Auditors:
Purchase the Hyphens Pharma International Limited report to view the information.
Incorporation Date:
2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Ownership Details
Purchase this report to view the information.
65.4%
Purchase this report to view the information.
14.6%
Company Performance
Financial values in the chart are available after Hyphens Pharma International Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-1.23%
Total operating revenue
-0.96%
Operating profit (EBIT)
11.16%
EBITDA
-6.4%
Net Profit (Loss) for the Period
20.7%
Total assets
6.87%
Total equity
12.55%
Operating Profit Margin (ROS)
0.76%
Net Profit Margin
1%
Return on Equity (ROE)
1.01%
Debt to Equity Ratio
-5.26%
Quick Ratio
0.17%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?